Sven Hoffner
Impact in
- Infectious Diseases top 0.1%
- Tuberculosis Research and Epidemiology
- Molecular Medicine top 0.5%
- Antibiotic Resistance in Bacteria
Papers in
-
- Tuberculosis Research and Epidemiology 102
- Epidemiology 72
- Mycobacterium research and diagnosis 64
- Pneumocystis jirovecii pneumonia detection and treatment 9
- Pneumonia and Respiratory Infections 7
- Co-authors
- Emma Huitric (3 shared papers)Gunilla Källenius (23 shared papers)Peter Verhasselt (2 shared papers)Koen Andries (2 shared papers)Jim Werngren (16 shared papers)Philip Timmerman (1 shared paper)Nacer Lounis (1 shared paper)Jean‐Marc Neefs (1 shared paper)
In The Last Decade
Sven Hoffner
127 papers receiving 6.4k citations
Sven Hoffner's Hit Papers
Peers
Comparison fields: 5 of 136
- Infectious Diseases 4.8k
- Molecular Medicine 579
- Epidemiology 3.3k
- Surgery 1.3k
- Toxicology 92
Countries citing papers authored by Sven Hoffner
This map shows the geographic impact of Sven Hoffner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sven Hoffner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sven Hoffner more than expected).
Fields of papers citing papers by Sven Hoffner
This network shows the impact of papers produced by Sven Hoffner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sven Hoffner. The network helps show where Sven Hoffner may publish in the future.
Co-authors
The 25 scholars most cited alongside Sven Hoffner, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 127 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | A Diarylquinoline Drug Active on the ATP Synthase of Mycobacterium tuberculosis Hit paper breakdown → | 2004 | 1656 |
| 2 | Global Trends in Resistance to Antituberculosis Drugs Hit paper breakdown → | 2001 | 518 |
| 3 | Emergence of New Forms of Totally Drug-Resistant Tuberculosis Bacilli Hit paper breakdown → | 2009 | 427 |
| 4 | 2012 | 151 | |
| 5 | 2012 | 141 | |
| 6 | 2005 | 140 | |
| 7 | 2009 | 139 | |
| 8 | 2007 | 132 | |
| 9 | 2014 | 123 | |
| 10 | 2012 | 120 | |
| 11 | 2006 | 119 | |
| 12 | 2011 | 105 | |
| 13 | 2009 | 93 | |
| 14 | 2003 | 87 | |
| 15 | 2010 | 87 | |
| 16 | 2008 | 82 | |
| 17 | 2013 | 80 | |
| 18 | 2009 | 78 | |
| 19 | 2011 | 74 | |
| 20 | 1999 | 73 |
About Sven Hoffner
Sven Hoffner is a scholar working on Infectious Diseases, Epidemiology, Surgery, Molecular Biology and Molecular Medicine, having authored 127 papers that have together received 6.7k indexed citations. Recurring topics across this work include Tuberculosis Research and Epidemiology (102 papers), Mycobacterium research and diagnosis (64 papers), Infectious Diseases and Tuberculosis (14 papers), Pneumocystis jirovecii pneumonia detection and treatment (9 papers), Diagnosis and treatment of tuberculosis (8 papers), Pneumonia and Respiratory Infections (7 papers), Antibiotic Resistance in Bacteria (6 papers) and Cancer therapeutics and mechanisms (6 papers). The work is most often cited by research in Infectious Diseases (4.8k citations), Molecular Medicine (579 citations), Epidemiology (3.3k citations), Surgery (1.3k citations) and Toxicology (92 citations). Sven Hoffner has collaborated with scholars based in Sweden, France and China. Frequent co-authors include Emma Huitric, Gunilla Källenius, Peter Verhasselt, Koen Andries, Jim Werngren, Philip Timmerman, Nacer Lounis, Jean‐Marc Neefs, Min Zhu and Hinrich W. H. Göhlmann. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, Journal of Clinical Microbiology, Journal of Antimicrobial Chemotherapy, European Journal of Clinical Microbiology & Infectious Diseases and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.